• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.50% Nasdaq Down2.41%

    Arbutus Biopharma Corporation (ABUS)

    -NasdaqGS
    3.34 Down 0.02(0.60%) 4:00PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue 24,873   14,953   15,465  
    Cost of Revenue -   -   -  
    Gross Profit 24,873   14,953   15,465  
    Operating Expenses
    Research Development51,505  38,713  21,458  
    Selling General and Administrative26,438  8,683  5,546  
    Non Recurring48,663  462   -  
    Others589  529  613  
    Total Operating Expenses127,195  48,387   -  
    Operating Income or Loss (102,322) (33,434) (12,152)
    Income from Continuing Operations
    Total Other Income/Expenses Net25,016  (5,403)(1,911)
    Earnings Before Interest And Taxes(77,306)(38,837)(14,063)
    Interest Expense -   -   -  
    Income Before Tax(77,306)(38,837)(14,063)
    Income Tax Expense(16,185) -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(61,121)(38,837)(14,063)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (61,121) (38,837) (14,063)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (61,121) (38,837) (14,063)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.